CSM Advisors »

Biosante Pharmaceuticals shares owned by CSM Advisors

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by CSM Advisors from 13F filings

Historical chart of CSM Advisors investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by CSM Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by CSM Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 28k 76.85

More positions owned by CSM Advisors

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Invesco Qqq Tr Qqq Trust Series 1 (QQQ)
Vanguard Index Tr Growth (VUG)
State St Spdr S&p500 Units Ser 1 S&p (SPY)
Alphabet Class A (GOOGL)
Vanguard Index Tr Value (VTV)
Amazon Common (AMZN)
Johnson & Johnson Common (JNJ)
Us Bancorp Del Common (USB)
Cisco Systems Common (CSCO)
Broadcom Common (AVGO)
Caterpillar Common (CAT)
Cummins Common (CMI)

View all positions for CSM Advisors

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Capital Management
Soleus Capital Management
State Street Corporation
Tang Capital Management
GoldenTree Asset Management
Deep Track Capital
Millennium Management
Arrowstreet Capital, Limited Partnership
Caption Management
Dimensional Fund Advisors
UBS Group
Geode Capital Management
Nuveen
Vanguard Portfolio Management

View all funds holding Biosante Pharmaceuticals